New Nasal Nanodrops Destroy Glioblastoma Tumors in Mice
  24. November 2025     Admin  

New Nasal Nanodrops Destroy Glioblastoma Tumors in Mice


Nasal nanodrops for brain tumor

Scientists have developed a **noninvasive nanotherapy**, delivered through the nose, that completely eliminated glioblastoma — one of the most aggressive brain tumors — in mice. This approach uses specially engineered nano‑structures to trigger the brain’s immune system.

Quick Insight: This therapy leverages “spherical nucleic acids” built around gold nanoparticles to activate a powerful immune pathway, without needing surgery or injections into the brain.

1. How It Works

• The nano‑structures are engineered to engage the **STING pathway**, a part of the immune system that helps detect and respond to threats.
• When administered as nasal drops, these particles travel along a nerve from the face into the brain, delivering their payload directly to immune cells.
• Once in the tumor region, they significantly activate immune cells, priming them to attack the cancer.

2. Results in Mice

• When combined with drugs that boost **T‑cells** (a key immune cell type), the treatment eradicated tumors in just one or two nasal doses.
• The mice also developed long‑term immune memory — meaning their bodies remained capable of fighting off the tumor if it tried to come back.
• Importantly, because the delivery is so targeted, side effects outside the brain were minimal.

3. Why This Is a Big Deal

• Glioblastoma is notoriously hard to treat, in part because it's difficult to deliver medicines into the brain safely.
• A noninvasive route like nasal drops could dramatically lower the barrier to therapy.
• By turning “cold” tumors (which don’t naturally trigger immune responses) into “hot” ones (which do), this approach could open up new paths for immunotherapy in brain cancer.

What’s Next

The research is still in the early stages (in mice), but it points toward a promising future: noninvasive, repeatable brain cancer therapy that could one day reduce the need for risky surgeries. Further testing is needed, especially to check safety, dosing, and whether the same approach works in larger or more complex animals — and maybe, eventually, humans.

Tip: Keep an eye on developments in **nanomedicine for brain therapy** — this field is evolving fast, and what works in mice today may shape future cancer treatments.



Comments Enabled

🎄